Please note that some translations using Google Translate may not be accurately represented, and image captions and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result for using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dana-Farber/Brigham and Women's Cancer Center offers a number of melanoma clinical trials. Our trials include studies in cutting-edge immunotherapy, chemotherapy, vaccines,
and novel targeted therapies to treat Stage III and IV melanoma.
Clinical research is a vital aspect of our mission. Our research not only gives current patients the opportunity to participate in clinical trials offering promising new treatments, but also aims to improve the lives of future generations of people with
We believe clinical research has a direct effect on clinical care, and our clinicians are actively involved in research. When questions arise in the clinic, clinician-researchers can answer them through clinical trials, and take the new knowledge back
to the clinic where it can benefit patients.
We aim to provide a broad range of options for high-risk melanoma patients or patients with metastatic disease, so that patients can be matched in trials that best fit their needs. Patients also have access to studies developed by specialists at other
US medical centers.
Appointments and Second Opinions